Boston Researchers Uncover Tumor Differences in Younger Colon Cancer Patients
Researchers in Boston have identified distinct tumor cell differences in younger colorectal cancer patients, which may inform future treatments.
BOSTON, Oct 31: Boston researchers have identified significant differences in colon cancer tumor cells in younger patients, potentially leading to improved treatments. This discovery comes as colorectal cancer rates increase among adults under 50, now the leading cause of cancer-related deaths in this age group, according to the American Cancer Society.
The study, conducted by scientists from Dana-Farber Cancer Institute, Mass General Brigham, and the Broad Institute, analyzed 189 tumors, including samples from over 50 patients under 50. Dr. Ana Anderson, a co-author of the study, said, “We found that stromal cells, the cells that make the connective tissue, are in higher proportion compared to the malignant cancer cells in the younger patient tumors.”
Researchers found that these stromal cells can hinder the immune response and form barriers that prevent effective drug delivery. The study also revealed that changes in gene expression may contribute to more aggressive forms of the disease in younger patients.
Kristen Vincent, a survivor diagnosed at 37, expressed hope for the impact of this research: “It’s exciting to me because the last thing I want is another young person with a young family to have to go through what I went through,” she said.
Dr. Kimmie Ng, another senior author of the study, noted the importance of understanding changes in tumors across age groups. While the exact reasons behind the rise in colorectal cancer among young adults remain unclear, the study identified a correlation between the higher presence of stromal cells and the more aggressive nature of tumors in younger individuals.
As the study emphasizes the differences in tumor biology, it also calls for further research to pinpoint the mechanisms behind these variations. Dr. Anderson stated, “Before we were just trying to look for differences, now we have some differences that we can kind of dig into further to hopefully understand biology, and that could lead to interventions down the road.”
Due to the increase in diagnoses, younger individuals are encouraged to be proactive about screening and addressing symptoms. Vincent urges those experiencing warning signs like blood in their stool to seek medical attention promptly.
While research into colorectal cancer in young patients advances, experts caution that significant breakthroughs may take time. Dr. Christina Annunziata from the American Cancer Society noted that understanding the early onset of cancer is crucial for developing preventive strategies.
Sources
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.